NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OxyPrem

OxyPrem

Private
ZurichHealthcare & Life Scienceshttps://www.oxyprem.com/

Last Round

Crowdfunding

Feb 28, 2025

Est. Valuation

$22.6M

Total Funding Raised

$5.86M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OxyPrem is a healthtech company that develops a medical silicon device to measure brain oxygen levels of preterm infants.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

tissue oximeterbrain oxygen monitoringnear-infrared spectroscopyNIRSpreterm infant monitoringneonatal monitoringpreemie monitoringcerebral oximetryNICUneonatology devicenon-invasive monitoringreusable sensorMedTechmedical devicemedical sensorsHealth IoTCE mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OxyPrem Comparables

Compare OxyPrem with similar companies based on industry and business-model similarity.

OxyPrem comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

OxyPrem Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingFeb 28, 2025
GrantJan 1, 2022
GrantAug 7, 2020
AcceleratorAug 2, 2019

Key People

Founding team and executive leadership

Stefan Kleiser

CTO

Executive Team

OxyPrem Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 3322% MoM, from 9 to 308.

  • Feb 28, 2025

    $3.3M raised from Capital Cell.

OxyPrem Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OxyPrem Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OxyPrem's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range18
Year Founded2018
Last FundingFeb 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.